Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

SYRE

Spyre Therapeutics, Inc.

CIK 0001636282 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$98.75
↑ 3.35 (3.51%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals, Options; Risks: Fundamentals

Key stats

Market Cap
$8.58B
P/E Ratio
-47.79
EPS
Not covered
Dividend Yield
Not covered
52W Position
96%
Beta
1.92

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
12.78
P/S
Not covered
EV/Revenue
Not covered
ROE
-26.7%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 96%
$14.51$102.06

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$155.20M
Total Assets
$777.78M
Free Cash Flow
–

Recent news